Relapsing fever cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Relapsing fever}} | {{Relapsing fever}} | ||
===Overview=== | ===Overview=== | ||
Although effective antibiotics are on the market, the disease remains a threat to people living in endemic areas. | |||
===Cost-effective of therapy=== | ===Cost-effective of therapy=== | ||
Revision as of 05:00, 25 September 2020
|
Relapsing fever Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Relapsing fever cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Relapsing fever cost-effectiveness of therapy |
|
Risk calculators and risk factors for Relapsing fever cost-effectiveness of therapy |
Overview
Although effective antibiotics are on the market, the disease remains a threat to people living in endemic areas.
Cost-effective of therapy
Although effective antibiotics are on the market, the disease remains a threat to people living in endemic areas.